Target Product Profile (TPP) Explained

A Target Product Profile (TPP) is a strategic, living document that defines the desired characteristics of a future medicine and aligns drug development with its intended regulatory label. By outlining target indications, patient populations, efficacy, safety, dosing, and pharmaceutical attributes, the TPP ensures every major development activity supports a clear end goal. It provides a shared framework for regulatory, non-clinical, clinical, CMC, and commercial teams, improving collaboration, resource allocation, and decision-making while reducing the risk of costly delays and disconnected studies.

As new data emerge, the TPP evolves from a vision-driven document in early discovery into a detailed, evidence-based roadmap that guides clinical development, regulatory interactions, valuation, and commercialization. It also enables proactive scenario planning by defining minimum and aspirational product profiles, helping teams navigate scientific and strategic challenges with confidence.

Uncover how a robust TPP transforms drug development into a focused, patient-centered pathway toward regulatory approval and commercial success by accessing the full article below.